As of 2025-12-23, the Relative Valuation of Vaxcyte Inc (PCVX) is (90.36) USD. This relative valuation is based on P/E multiples. With the latest stock price at 48.07 USD, the upside of Vaxcyte Inc based on Relative Valuation is -288.0%.
The range of the Relative Valuation is (66.77) - (112.75) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.2x - 22.5x | 17.9x |
| Forward P/E multiples | 13.3x - 29.1x | 18.1x |
| Fair Price | (66.77) - (112.75) | (90.36) |
| Upside | -238.9% - -334.6% | -288.0% |
| Date | P/E |
| 2025-12-19 | -9.25 |
| 2025-12-18 | -8.71 |
| 2025-12-17 | -8.58 |
| 2025-12-16 | -8.70 |
| 2025-12-15 | -8.83 |
| 2025-12-12 | -8.86 |
| 2025-12-11 | -8.88 |
| 2025-12-10 | -8.66 |
| 2025-12-09 | -8.91 |
| 2025-12-08 | -9.20 |
| 2025-12-05 | -9.26 |
| 2025-12-04 | -9.18 |
| 2025-12-03 | -9.50 |
| 2025-12-02 | -8.90 |
| 2025-12-01 | -9.07 |
| 2025-11-28 | -9.88 |
| 2025-11-26 | -9.89 |
| 2025-11-25 | -10.01 |
| 2025-11-24 | -9.81 |
| 2025-11-21 | -9.52 |
| 2025-11-20 | -9.50 |
| 2025-11-19 | -9.68 |
| 2025-11-18 | -9.87 |
| 2025-11-17 | -9.63 |
| 2025-11-14 | -9.70 |
| 2025-11-13 | -9.07 |
| 2025-11-12 | -9.18 |
| 2025-11-11 | -9.10 |
| 2025-11-10 | -8.55 |
| 2025-11-07 | -8.30 |
| 2025-11-06 | -8.31 |
| 2025-11-05 | -8.03 |
| 2025-11-04 | -8.24 |
| 2025-11-03 | -8.53 |
| 2025-10-31 | -9.02 |
| 2025-10-30 | -8.91 |
| 2025-10-29 | -8.67 |
| 2025-10-28 | -8.88 |
| 2025-10-27 | -8.88 |
| 2025-10-24 | -8.41 |
| 2025-10-23 | -8.29 |
| 2025-10-22 | -8.47 |
| 2025-10-21 | -8.44 |
| 2025-10-20 | -8.55 |
| 2025-10-17 | -8.44 |
| 2025-10-16 | -8.68 |
| 2025-10-15 | -8.75 |
| 2025-10-14 | -8.54 |
| 2025-10-13 | -8.73 |
| 2025-10-10 | -8.70 |